Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters - Greece
doi 10.3892/ol.2018.9799
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

miR‑320a Is an Independent Prognostic Biomarker for Invasive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Correction: Genomic Deletion of Chromosome 12p Is an Independent Prognostic Marker in Prostate Cancer

Oncotarget
Oncology
2017English

Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Elevated Serum RAS P21 Is an Independent Prognostic Factor in Metastatic Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Low Residual Proliferation After Short-Term Letrozole Therapy Is an Early Predictive Marker of Response in High Proliferative ER-positive Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2011English

Is Collagen an Independent Risk Factor for Breast Cancer?

2016English

Mode of Detection: An Independent Prognostic Factor for Women With Breast Cancer

Journal of Medical Screening
Health PolicyPublic HealthOccupational HealthEnvironmental
2015English

Overexpression of CXXC5 Is a Strong Poor Prognostic Factor in ER+ Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy